On the other hand, there was no evidence of increased immunostaining for phospho-AKT (Fig 4E) and phospho-ERK (Fig 4G) in the tumor or at the margin between liver and tumor in the sham ablation group. This evidence concerns the gene MAPK1 and neoplasm.